Help the John J. Abel Award endowment fund grow. The Abel Award honors young investigators who are doing fundamental research in pharmacology and experimental therapeutics. Donate Now.
Joint Annual Meeting of ASPET and the Chinese
Pharmacological Society at EB 2014 in San Diego, April 26 - 30,
students and postdocs: Applications are now open for the 2015 ASPET
Washington Fellows program!
Check out ASPET’s new Guide to Member Benefits for a detailed listing of your benefits. Be sure to take advantage of your membership today!
recognizes Dr. R. Clinton Webb from the Cardiovascular Pharmacology
Forgot your password?
Find us on the popular social networks
The countdown begins! The ASPET 2014 Annual Meeting is only two weeks away! Click here to view our program.
Take a look at what's happening at ASPET. View the current edition of our eNewsletter.
CSR's Early Career Reviewer (ECR) program was developed to train qualified scientists without prior scientific review experience to become effective reviewers and to help advance their careers by exposing them to peer review.
Dr. Alphonse J. Ingenito's book "Drug Therapy: Yesterday, Today and Tomorrow—Basic Fundamentals for the Non-Scientist” was recently published by Dog Ear Publishing. The book is a primer of basic fundamentals of pharmacology and drug therapy intended for the average layperson lacking a scientific background.
Recently I made the transition from academic research to a career in intellectual property (IP). Specifically, I made the jump from postdoctoral fellow to my university’s technology transfer office as an intellectual property officer. Given that many of you are probably postdocs or grad students, and that at least a few of you might be interested in careers outside of academic research, I was asked if I could talk a little about IP careers and how I made the transition.
In a recent ground-breaking study, Dr. Solomon Snyder and his team of researchers at Johns Hopkins University have reported that a cellular mechanism in the genetic mutation causes the vast neurodegeneration that ultimately leads to Huntington’s disease.
March 2014 - Volume 56, Issue 1The Pharmacologist has been newly re-designed to reflect our new logo and brand. Check out the March issue, featuring an article by Dr. Rebecca Anderson, Oat Sprouts and the Topliss Tree: Rationalizing SAR. Also in this issue, read about the 2014 ASPET Award Winners, see the complete ASPET Program for EB, and much more.
Read through our
archive of past news and access links to previous eNewsletters, member news, science policy updates, and more.
House Budget Chair Paul Ryan (R-WI) released the House Republican budget resolution for FY 2015. The budget proposal intends to cut government spending by more than $5 trillion over ten years. The Ryan budget keeps the FY 2015 discretionary spending caps intact as agreed to by Democrats and Republicans in last December’s budget agreement. However, in FY 2016 the Ryan budget breaches this agreement and increases spending on defense by $43 million while cutting non-defense discretionary spending by the same amount. If the Ryan budget was adopted, it would cut domestic spending 30% below current levels in 2024.
ASPET is pleased to submit written testimony in support of the National Institutes of Health (NIH) FY 2015 budget. ASPET recommends a FY 2015 NIH budget of at least $32 billion.
A new Congressional Research Service (CRS) report, A History of NIH Funding, found that adjusting for inflation, FY 2014 funding for the NIH is 22 percent lower than it was in FY 2003.
On January 31, 2014, ASPET sent a letter expressing
appreciation to Congressional Appropriators for prioritizing FDA funding in the
FY2014 appropriations bill and releasing sequestered users' fees.
Read through our archive of past science policy updates and news.
© Copyright 2014
The American Society for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, Maryland 20814-3995
ASPET.org is best viewed with Internet Explorer 7+, Firefox 3.5+ and Safari 3+.